SG Americas Securities LLC Sells 34,426 Shares of Progyny, Inc. (NASDAQ:PGNY)

SG Americas Securities LLC trimmed its position in Progyny, Inc. (NASDAQ:PGNYGet Rating) by 77.0% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 10,298 shares of the company’s stock after selling 34,426 shares during the period. SG Americas Securities LLC’s holdings in Progyny were worth $529,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the company. FourThought Financial LLC grew its position in Progyny by 24.3% in the 1st quarter. FourThought Financial LLC now owns 11,762 shares of the company’s stock worth $605,000 after purchasing an additional 2,297 shares in the last quarter. TownSquare Capital LLC bought a new stake in Progyny in the 1st quarter worth about $559,000. DekaBank Deutsche Girozentrale grew its position in Progyny by 20.8% in the 1st quarter. DekaBank Deutsche Girozentrale now owns 31,400 shares of the company’s stock worth $1,598,000 after purchasing an additional 5,400 shares in the last quarter. Hardy Reed LLC bought a new stake in Progyny in the 1st quarter worth about $117,000. Finally, Comerica Bank grew its position in Progyny by 1.2% in the 1st quarter. Comerica Bank now owns 32,627 shares of the company’s stock worth $1,441,000 after purchasing an additional 380 shares in the last quarter. 82.51% of the stock is owned by institutional investors.

Insider Activity

In other news, Director Norman Payson sold 6,618 shares of the stock in a transaction that occurred on Wednesday, May 11th. The shares were sold at an average price of $33.45, for a total transaction of $221,372.10. Following the completion of the transaction, the director now directly owns 490,828 shares of the company’s stock, valued at approximately $16,418,196.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, Chairman David J. Schlanger sold 1,452 shares of the firm’s stock in a transaction that occurred on Monday, June 27th. The shares were sold at an average price of $31.21, for a total value of $45,316.92. Following the completion of the transaction, the chairman now directly owns 82,548 shares of the company’s stock, valued at approximately $2,576,323.08. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Norman Payson sold 6,618 shares of the firm’s stock in a transaction that occurred on Wednesday, May 11th. The stock was sold at an average price of $33.45, for a total transaction of $221,372.10. Following the completion of the transaction, the director now directly owns 490,828 shares of the company’s stock, valued at $16,418,196.60. The disclosure for this sale can be found here. Insiders sold 34,622 shares of company stock valued at $1,078,038 in the last three months. Company insiders own 14.00% of the company’s stock.

Progyny Stock Performance

Shares of PGNY stock opened at $29.77 on Friday. Progyny, Inc. has a 52-week low of $25.67 and a 52-week high of $68.32. The company has a 50-day simple moving average of $30.09 and a two-hundred day simple moving average of $37.36. The company has a market capitalization of $2.74 billion, a price-to-earnings ratio of 53.16, a PEG ratio of 16.23 and a beta of 1.85.

Progyny (NASDAQ:PGNYGet Rating) last released its earnings results on Thursday, May 5th. The company reported $0.05 earnings per share for the quarter, beating analysts’ consensus estimates of $0.02 by $0.03. Progyny had a net margin of 10.09% and a return on equity of 23.15%. The firm had revenue of $172.22 million during the quarter, compared to the consensus estimate of $167.49 million. On average, sell-side analysts forecast that Progyny, Inc. will post 0.09 EPS for the current fiscal year.

Progyny Profile

(Get Rating)

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.

Read More

Institutional Ownership by Quarter for Progyny (NASDAQ:PGNY)

Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.